logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

YOHO GROUP (02347) spent 1.1894 million Hong Kong dollars on March 25 to repurchase 1.888 million shares.

date
17:47 25/03/2026
avatar
GMT Eight
Yoho Group (02347) announced that it will repurchase 1,188,000 shares for a total of 11.894 million Hong Kong dollars on March 25, 2026.
YOHO GROUP (02347) announced on March 25, 2026, that it will spend HK$11.894 million to repurchase 1.88 million shares.
Related Articles
HK Stock
Chuan Holding (01420) announces a profit surge. It is expected that the shareholders' net profit will increase significantly by approximately 132.9% in 2025.
HK Stock
NT PHARMA (01011) completed the acquisition of 58.11% equity stake in Zhejiang Kangyuan Medical Devices.
China Stock
China Life Insurance plans to invest 2.8 billion yuan to participate in the establishment of Fujian Province Xinrui Science and Technology Innovation Relay Equity Investment Fund.
Chuan Holding (01420) announces a profit surge. It is expected that the shareholders' net profit will increase significantly by approximately 132.9% in 2025.
HK Stock
NT PHARMA (01011) completed the acquisition of 58.11% equity stake in Zhejiang Kangyuan Medical Devices.
HK Stock
China Life Insurance plans to invest 2.8 billion yuan to participate in the establishment of Fujian Province Xinrui Science and Technology Innovation Relay Equity Investment Fund.
China Stock
RECOMMEND
Pace Of Public Fund Issuance Slows, Hong Kong Stocks Become A Primary Focus
Pace Of Public Fund Issuance Slows, Hong Kong Stocks Become A Primary Focus
icon
24/03/2026
Jensen Huang In‑Depth Interview: Token Economy Surge, AI Computing’s Share Of GDP To Multiply One Hundredfold, NVIDIA’s $10 Trillion Valuation Inevitable
Jensen Huang In‑Depth Interview: Token Economy Surge, AI Computing’s Share Of GDP To Multiply One Hundredfold, NVIDIA’s $10 Trillion Valuation Inevitable
icon
24/03/2026
Are U.S.‑Iran Talks Genuine? At Minimum, Wall Street Read A Clear Signal From Trump’s Five‑Minute Rally
Are U.S.‑Iran Talks Genuine? At Minimum, Wall Street Read A Clear Signal From Trump’s Five‑Minute Rally
icon
24/03/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.